Tamar Ziehm

Tamar Ziehm

Auto-generated profile, based on publicly available information

Tamar Ziehm

Institute of Biological Information Processing (IBI-7: Structural Biochemistry), Forschungszentrum Jülich, Jülich, Germany

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
NJNan Jiang
Nan Jiang
LLLeonie H. E. Leithold
Leonie H. E. Leithold
JPJulia Post
Julia Post
TZTamar Ziehm
Tamar Ziehm
JMJörg Mauler
Jörg Mauler
AWAntje Willuweit
Antje Willuweit
Targeting toxic amyloid beta (Aβ) oligomers is currently a very attractive drug development strategy for treatment of Alzheimer´s disease. Using mirror-image phage display against Aβ1-42, we have previously identified the fully D-enantiomeric peptide D3, which is able to eliminate Aβ oligomers and has proven therapeutic potential in transgenic Alzheimer´s disease animal models. However, there is little information on the pharmacokinetic behaviour of D-enantiomeric peptides in general. Therefore, we conducted experiments with the tritium labelled D-peptide D3 (3H-D3) in mice with different administration routes to study its distribution in liver, kidney, brain, plasma and gastrointestinal tract, as well as its bioavailability by i.p. and p.o. administration. In addition, we investigated the metabolic stability in liver microsomes, mouse plasma, brain, liver and kidney homogenates, and estimated the plasma protein binding. Based on its high stability and long biological half-life, our pharmacokinetic results support the therapeutic potential of D-peptides in general, with D3 being a new promising drug candidate for Alzheimer´s disease treatment.

17 September 2015 in Pharmaceutical Research
Verified
Journal Article
Closed access
PDF file
LLLeonie H. E. Leithold
Leonie H. E. Leithold
NJNan Jiang
Nan Jiang
JPJulia Post
Julia Post
TZTamar Ziehm
Tamar Ziehm
ESElena Schartmann
Elena Schartmann
DWDieter Willbold
Dieter Willbold

9 June 2016 in ACS Chemical Neuroscience
Verified
Journal Article
Closed access
TZTamar Ziehm
Tamar Ziehm
OBOleksandr Brener
Oleksandr Brener
TGThomas van Groen
Thomas van Groen
IKInga Kadish
Inga Kadish
DFDaniel Frenzel
Daniel Frenzel
DWDieter Willbold
Dieter Willbold

22 April 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AKAntonia Nicole Klein
Antonia Nicole Klein
TZTamar Ziehm
Tamar Ziehm
MTMarkus Tusche
Markus Tusche
JBJohan Buitenhuis
Johan Buitenhuis
DBDirk Bartnik
Dirk Bartnik
DWDieter Willbold
Dieter Willbold
The aggregation of amyloid-β (Aβ) is postulated to be the crucial event in Alzheimer’s disease (AD). In particular, small neurotoxic Aβ oligomers are considered to be responsible for the development and progression of AD. Therefore, elimination of thesis oligomers represents a potential causal therapy of AD. Starting from the well-characterized d-enantiomeric peptide D3, we identified D3 derivatives that bind monomeric Aβ. The underlying hypothesis is that ligands bind monomeric Aβ and stabilize these species within the various equilibria with Aβ assemblies, leading ultimately to the elimination of Aβ oligomers. One of the hereby identified d-peptides, DB3, and a head-to-tail tandem of DB3, DB3DB3, were studied in detail. Both peptides were found to: (i) inhibit the formation of Thioflavin T-positive fibrils; (ii) bind to Aβ monomers with micromolar affinities; (iii) eliminate Aβ oligomers; (iv) reduce Aβ-induced cytotoxicity; and (v) disassemble preformed Aβ aggregates. The beneficial effects of DB3 were improved by DB3DB3, which showed highly enhanced efficacy. Our approach yielded Aβ monomer-stabilizing ligands that can be investigated as a suitable therapeutic strategy against AD.

13 April 2016 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
LLLeonie H.E. Leithold
Leonie H.E. Leithold
NJNan Jiang
Nan Jiang
JPJulia Post
Julia Post
NNNicole Niemietz
Nicole Niemietz
ESElena Schartmann
Elena Schartmann
DWDieter Willbold
Dieter Willbold

1 May 2021 in Neuroscience
Verified
Journal Article
Closed access
AAAlexandra Albus
Alexandra Albus
YKYannick Kronimus
Yannick Kronimus
SNSascha Neumann
Sascha Neumann
NVNatascha Vidovic
Natascha Vidovic
AFAndré Frenzel
André Frenzel
RDRichard Dodel
Richard Dodel